These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 21257598

  • 21. Antimicrobial Resistance in Rhodococcus equi.
    Giguère S, Berghaus LJ, Willingham-Lane JM.
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052538
    [Abstract] [Full Text] [Related]

  • 22. Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.
    Anastasi E, Giguère S, Berghaus LJ, Hondalus MK, Willingham-Lane JM, MacArthur I, Cohen ND, Roberts MC, Vazquez-Boland JA.
    J Antimicrob Chemother; 2015 Dec; 70(12):3184-90. PubMed ID: 26377866
    [Abstract] [Full Text] [Related]

  • 23. Peritoneal fluid from a febrile foal.
    Bohn AA, Rothschild C.
    Vet Clin Pathol; 2002 Dec; 31(4):189-91. PubMed ID: 12447781
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Appearance of multidrug-resistant virulent Rhodococcus equi clinical isolates obtained in China.
    Liu H, Wang Y, Yan J, Wang C, He H.
    J Clin Microbiol; 2014 Feb; 52(2):703. PubMed ID: 24478520
    [No Abstract] [Full Text] [Related]

  • 26. [Diagnosis and therapy of Rhodococcus equi infection in the horse].
    Boswinkel M, Sloet van Oldruitenborgh-Oosterbaan MM.
    Tijdschr Diergeneeskd; 2006 Sep 01; 131(17):602-11. PubMed ID: 16989420
    [Abstract] [Full Text] [Related]

  • 27. In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.
    Schlusselhuber M, Jung S, Bruhn O, Goux D, Leippe M, Leclercq R, Laugier C, Grötzinger J, Cauchard J.
    Antimicrob Agents Chemother; 2012 Apr 01; 56(4):1749-55. PubMed ID: 22232283
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of Macrolide and Rifampin Resistance on Fitness of Rhodococcus equi during Intramacrophage Replication and In Vivo.
    Willingham-Lane JM, Berghaus LJ, Berghaus RD, Hart KA, Giguère S.
    Infect Immun; 2019 Oct 01; 87(10):. PubMed ID: 31331959
    [Abstract] [Full Text] [Related]

  • 31. Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis.
    Erol E, Locke S, Saied A, Cruz Penn MJ, Smith J, Fortner J, Carter C.
    Vet Microbiol; 2020 Mar 01; 242():108568. PubMed ID: 32122582
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.
    Cohen ND, Slovis NM, Giguère S, Baker S, Chaffin MK, Bernstein LR.
    J Vet Intern Med; 2015 Mar 01; 29(3):932-9. PubMed ID: 25868480
    [Abstract] [Full Text] [Related]

  • 34. International Spread of Multidrug-Resistant Rhodococcus equi.
    Val-Calvo J, Darcy J, Gibbons J, Creighton A, Egan C, Buckley T, Schmalenberger A, Fogarty U, Scortti M, Vázquez-Boland JA.
    Emerg Infect Dis; 2022 Sep 01; 28(9):1899-1903. PubMed ID: 35997496
    [Abstract] [Full Text] [Related]

  • 35. Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals.
    Giguère S, Cohen ND, Chaffin MK, Slovis NM, Hondalus MK, Hines SA, Prescott JF.
    J Vet Intern Med; 2011 Sep 01; 25(6):1209-20. PubMed ID: 22092608
    [Abstract] [Full Text] [Related]

  • 36. Failure of antimicrobial therapy to accelerate spontaneous healing of subclinical pulmonary abscesses on a farm with endemic infections caused by Rhodococcus equi.
    Venner M, Rödiger A, Laemmer M, Giguère S.
    Vet J; 2012 Jun 01; 192(3):293-8. PubMed ID: 21924651
    [Abstract] [Full Text] [Related]

  • 37. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi.
    Giguère S, Lee EA, Guldbech KM, Berghaus LJ.
    Vet Microbiol; 2012 Nov 09; 160(1-2):207-13. PubMed ID: 22704561
    [Abstract] [Full Text] [Related]

  • 38. Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA.
    Huber L, Giguère S, Cohen ND, Slovis NM, Hanafi A, Schuckert A, Berghaus L, Greiter M, Hart KA.
    Vet Microbiol; 2019 Aug 09; 235():243-247. PubMed ID: 31383308
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.
    Burton AJ, Giguère S, Berghaus LJ, Hondalus MK.
    Antimicrob Agents Chemother; 2015 Aug 09; 59(6):3633-6. PubMed ID: 25824218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.